Viacyte developed VC-01 after more than 15 years of research on using stem cell technology to treat Diabetes Type 1. VC-01 is now in clinical trials in the US and Canada to test if it's stem cell therapy can help treat Diabetes Type 1. In his interview with KZSU, Dr. Laikind, Viacyte's CEO, discussed how VC-01 works, how this technology has cured diabetes in the animal model, how VC-01 might help treat patients with Type 1 Diabetes and how to find out about the clinical trials of VC-01. making VC-01 successful so far.